Lifeward (LFWD) Competitors $0.61 -0.11 (-14.64%) Closing price 04:00 PM EasternExtended Trading$0.64 +0.03 (+4.08%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock LFWD vs. CLGN, VVOS, FEMY, DRIO, RVP, PETV, IRIX, ALUR, NXGL, and NRXSShould you be buying Lifeward stock or one of its competitors? The main competitors of Lifeward include CollPlant Biotechnologies (CLGN), Vivos Therapeutics (VVOS), Femasys (FEMY), DarioHealth (DRIO), Retractable Technologies (RVP), PetVivo (PETV), IRIDEX (IRIX), Allurion Technologies (ALUR), NexGel (NXGL), and NeurAxis (NRXS). These companies are all part of the "medical equipment" industry. Lifeward vs. Its Competitors CollPlant Biotechnologies Vivos Therapeutics Femasys DarioHealth Retractable Technologies PetVivo IRIDEX Allurion Technologies NexGel NeurAxis Lifeward (NASDAQ:LFWD) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership. Which has more volatility and risk, LFWD or CLGN? Lifeward has a beta of 0.09, indicating that its share price is 91% less volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500. Is LFWD or CLGN more profitable? Lifeward has a net margin of -108.21% compared to CollPlant Biotechnologies' net margin of -560.92%. CollPlant Biotechnologies' return on equity of -87.33% beat Lifeward's return on equity.Company Net Margins Return on Equity Return on Assets Lifeward-108.21% -101.96% -70.49% CollPlant Biotechnologies -560.92%-87.33%-65.31% Do institutionals and insiders hold more shares of LFWD or CLGN? 26.8% of Lifeward shares are held by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are held by institutional investors. 2.7% of Lifeward shares are held by company insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media refer more to LFWD or CLGN? In the previous week, Lifeward had 11 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 14 mentions for Lifeward and 3 mentions for CollPlant Biotechnologies. CollPlant Biotechnologies' average media sentiment score of 0.63 beat Lifeward's score of 0.06 indicating that CollPlant Biotechnologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lifeward 1 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CollPlant Biotechnologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, LFWD or CLGN? CollPlant Biotechnologies has lower revenue, but higher earnings than Lifeward. CollPlant Biotechnologies is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifeward$25.66M0.26-$28.94M-$3.04-0.20CollPlant Biotechnologies$510K65.10-$16.61M-$1.22-2.14 Do analysts prefer LFWD or CLGN? Lifeward currently has a consensus price target of $9.00, suggesting a potential upside of 1,370.59%. CollPlant Biotechnologies has a consensus price target of $11.50, suggesting a potential upside of 340.61%. Given Lifeward's higher probable upside, equities research analysts plainly believe Lifeward is more favorable than CollPlant Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifeward 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00CollPlant Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryCollPlant Biotechnologies beats Lifeward on 8 of the 15 factors compared between the two stocks. Get Lifeward News Delivered to You Automatically Sign up to receive the latest news and ratings for LFWD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFWD vs. The Competition Export to ExcelMetricLifewardINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$7.89M$19.79B$30.05B$9.84BDividend YieldN/A3.37%3.08%4.07%P/E Ratio-0.2073.3952.1925.74Price / Sales0.26206.821,274.26115.83Price / CashN/A84.0936.4959.48Price / Book0.2918.029.126.15Net Income-$28.94M$347.70M$803.97M$265.06M7 Day Performance-10.00%-0.20%1.26%2.80%1 Month Performance-18.40%-0.34%0.76%1.68%1 Year Performance-80.26%68.10%24,023.69%29.59% Lifeward Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFWDLifeward2.6945 of 5 stars$0.61-14.6%$9.00+1,370.6%-77.4%$7.89M$25.66M-0.2060Trending NewsGap DownHigh Trading VolumeCLGNCollPlant Biotechnologies2.8907 of 5 stars$2.25-0.2%$11.50+412.0%-39.3%$28.57M$510K-1.8470News CoverageUpcoming EarningsVVOSVivos Therapeutics0.8767 of 5 stars$4.85+1.9%$4.82-0.7%+100.4%$28.56M$15.03M-2.80160News CoverageGap DownFEMYFemasys2.953 of 5 stars$0.84+3.9%$8.67+931.7%-29.7%$27.32M$1.70M-0.9230News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionGap UpDRIODarioHealth1.4778 of 5 stars$0.57+3.6%$2.00+250.9%-50.8%$25.49M$27.04M-1.00200News CoverageGap DownRVPRetractable Technologies1.9945 of 5 stars$0.74+0.7%N/A-22.8%$22.01M$33.75M-1.36240News CoverageShort Interest ↑Gap UpPETVPetVivoN/A$0.80-1.0%N/A+68.3%$22.00M$1.05M-1.7820News CoverageGap DownIRIXIRIDEX1.265 of 5 stars$1.31-0.8%N/A-40.1%$21.99M$48.80M-3.05120News CoveragePositive NewsEarnings ReportALURAllurion Technologies2.6122 of 5 stars$2.74-3.9%$22.83+733.3%-86.8%$20.74M$32.11M-0.22501News CoverageShort Interest ↓Analyst RevisionNXGLNexGel1.3932 of 5 stars$2.66+2.2%N/A-13.7%$20.16M$8.69M-5.8610News CoverageEarnings ReportUpcoming EarningsShort Interest ↓NRXSNeurAxis2.8442 of 5 stars$2.54+0.8%$7.00+175.6%-22.2%$18.33M$2.93M-1.3819News CoverageShort Interest ↑Gap Up Related Companies and Tools Related Companies CollPlant Biotechnologies Competitors Vivos Therapeutics Competitors Femasys Competitors DarioHealth Competitors Retractable Technologies Competitors PetVivo Competitors IRIDEX Competitors Allurion Technologies Competitors NexGel Competitors NeurAxis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFWD) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifeward Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifeward With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access